mCRPC

UROwebinar: New treatment1:04:24

UROwebinar: New treatment options in mCRPC

Metastatic Castration Resistant0:16:39

Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved Outcomes

The Differences Between0:02:50

The Differences Between mCRPC and nmCRPC

ADT Resistant Metastatic0:15:37

ADT Resistant Metastatic Prostate Cancer (mCRPC) - 2021 Prostate Cancer Patient Conference

Rapidly Expanding Options0:02:54

Rapidly Expanding Options in mCRPC

Improving the Prognosis0:04:56

Improving the Prognosis for Patients With mCRPC

Managing Bone Metastasis0:05:57

Managing Bone Metastasis in Patients With mCRPC

The evolving treatment0:01:23

The evolving treatment landscape of mHSPC and mCRPC

First-line treatments for0:02:34

First-line treatments for patients with mHSPC and mCRPC

Impressions of a0:03:51

Impressions of a Patient With Progression to mCRPC

VISION: 177Lu-PSMA-617 in0:01:28

VISION: 177Lu-PSMA-617 in PSMA-positive mCRPC

Case 3: Treatment0:07:52

Case 3: Treatment After Progression to mCRPC

The Best Therapy0:03:06

The Best Therapy Option for a Patient With mCRPC

Dr. Sehdev, Medical0:01:05

Dr. Sehdev, Medical Oncologist: What is mCRPC and what is the prognosis?

mCRPC: Sequencing Therapy0:03:09

mCRPC: Sequencing Therapy

Early use of0:02:46

Early use of radium-223 is beneficial for asymptomatic mCRPC

Treatment sequencing in0:01:52

Treatment sequencing in mCRPC: cabazitaxel vs. abiraterone or enzalutamide

Cabazitaxel Improves rPFS0:01:22

Cabazitaxel Improves rPFS in Patients with mCRPC

OS after progression0:01:46

OS after progression on first novel hormonal therapy in mCSPC vs mCRPC

Radioligand therapy for0:02:18

Radioligand therapy for mCRPC

Dr. Dorff on0:01:38

Dr. Dorff on Role of Chemotherapy in mCRPC

Bone Versus Visceral0:05:47

Bone Versus Visceral Metastases in mCRPC

Ep. 10: How0:08:21

Ep. 10: How Has the mCRPC Treatment Landscape Changed?

Management of mCRPC0:14:14

Management of mCRPC in China